Working with week-old zebrafish larva, researchers at Weill Cornell Medicine and colleagues decoded how the connections formed by a network of neurons in the brainstem guide the fishes’ gaze.
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
Eclectic Convergence, a yearly event hosted by Entrepreneurship at Cornell, included featured speakers, networking, a pitch contest and tabling by student businesses.
A new study by Cornell information science researchers finds that ignoring race in college admissions leads to an admitted class that is much less diverse, but with similar academic credentials to those where affirmative action is factored in.
Hospices are increasingly owned by private equity firms and publicly traded companies, but recently Weill Cornell Medicine researchers found that they performed substantially worse than hospices owned by not-for-profit agencies.
Weill Cornell Medicine and the Cornell Jeb E. Brooks School of Public Policy have established the Cornell Health Policy Center to serve as the locus for health policy impact, research and training across Cornell.
Weill Cornell Medicine researchers have determined the full-length structure and function of a blood pressure-regulating hormone receptor, which may enable better drug targeting of the receptor for diseases such as hypertension and heart failure.
The new “How NYC Moves” report, co-authored by a Cornell Tech expert and New York City’s Mayor’s Office, offers strategies to leverage technology to speed transportation analyses and unlock housing development.
A new analysis finds that Cornell Tech, its alumni and startups achieved $768 million in total economic impact in New York City in the 2023-24 fiscal year. That impact is expected to reach $1.5 billion by 2030.
